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Abstract
Fibroblast growth factor 10 (Fgf10) is a key regulator of diverse organogenetic programs during mouse development,
particularly branching morphogenesis. Fgf10-null mice suffer from lung and limb agenesis as well as cecal and colonic
atresia and are thus not viable. To date, the Mlcv1v-nLacZ-24 transgenic mouse strain (referred to as Fgf10LacZ), which carries
a LacZ insertion 114 kb upstream of exon 1 of Fgf10 gene, has been the only strain to allow transient lineage tracing of
Fgf10-positive cells. Here, we describe a novel Fgf10Cre-ERT2 knock-in line (Fgf10iCre) in which a Cre-ERT2-IRES-YFP cassette has
been introduced in frame with the ATG of exon 1 of Fgf10 gene. Our studies show that Cre-ERT2 insertion disrupts Fgf10
function. However, administration of tamoxifen to Fgf10iCre; Tomatoflox double transgenic embryos or adult mice results in
specific labeling of Fgf10-positive cells, which can be lineage-traced temporally and spatially. Moreover, we show that the
Fgf10iCre line can be used for conditional gene inactivation in an inducible fashion during early developmental stages. We
also provide evidence that transcription factors located in the first intron of Fgf10 gene are critical for maintaining Fgf10
expression over time. Thus, the Fgf10iCre line should serve as a powerful tool to explore the functions of Fgf10 in a controlled
and stage-specific manner.
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Introduction
Fibroblast growth factor 10 (Fgf10) signals through its epithelial
receptor Fgfr2b and is critical for branching morphogenesis in the
mouse embryo. Loss of function of either Fgf10 or Fgfr2b by genetic
deletion leads to total failure of lung and limb formation as well as
cecal and colonic atresia [1,2,3,4,5]. In addition to its vital role
during development, Fgf10 over-expression attenuates bleomycin-
induced pulmonary fibrosis in mice [6].
Using enhancer-trap strategies, the Mlcv1v-nLacZ-24 transgenic
mouse line (hereby referred to as Fgf10LacZ) was characterized. The
LacZ cassette was mapped and found to be integrated within
regulatory elements lying 114 kb upstream of the endogenous
Fgf10 coding sequence [7]. LacZ expression pattern observed in
these mice closely mimics Fgf10 expression in the heart, lung, gut,
mammary glands and brain [4,5,7,8,9,10,11]. The Fgf10LacZ
mouse reports Fgf10 expression and also results in a Fgf10
hypomorph as demonstrated by the phenotype of Fgf10LacZ/2 (one
copy of Fgf10 null and one copy of Fgf10LacZ) embryos. These
embryos display decreased lung branching [12] as well as
mammary gland [10] and limb abnormalities (Hajihosseini and
Bellusci, unpublished results) consistent with decreased Fgf10
expression.
Until recently, the Fgf10LacZ transgenic line has been the only
available tool that can be used to transiently trace Fgf10-positive
cells in mice. Here, we describe a novel Fgf10iCre knock-in line
where a tamoxifen-inducible Cre recombinase (Cre-ERT2-IRES-
YFP) has been inserted in frame with the start codon of exon 1
of the endogenous Fgf10 gene (Fig.1). Our validation studies
show that Fgf10iCre is a loss of function allele for Fgf10. At the
heterozygous state, this line is viable and fertile whereas the
homozygous state is lethal. By crossing this line with a Tomatoflox
reporter line, we show that Fgf10-positive cells are specifically
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labeled upon tamoxifen administration in many tissues during
embryonic and postnatal stages. Moreover, we demonstrate that
crossing Fgf10iCre driver line with responder lines carrying ‘floxed’
genes allows inducible conditional gene inactivation, but to a
limited extent. This is because the expression of Cre from the
recombined Fgf10 locus reveals mosaicism in the labeled tissues
and tends to decline with developmental progression. This is
probably due to disruption of regulatory elements downstream of
exon 1 where the cassette has been initially inserted. The mosaic
recombination pattern observed in this genetic model is a
valuable tool for clonal analysis and lineage tracing of Fgf10-
positive cells.
Materials and Methods
Targeting strategy of the endogenous Fgf10 locus to generate
C57BL/6-Fgf10Cre-ERT2-YFP/J knock-in mice.
59 and 39 homology regions (10.3 kb) for Fgf10 were amplified
by PCR using DNA from a Fgf10-specific BAC clone derived
from a BAC library of 129Sv/AB2.2 mouse strain (Wellcome
Trust Sanger Institute). The isolated sequences were used to
design the targeting construct. The linearized targeting construct
was transfected into TVB2 mouse ES cells (following the
electroporation procedure: 56106 ES cells in presence of 40 mg
of linearized plasmid, 260 Volt, 500 mF). Positive selection was
started 48 hours after electroporation by addition of 200 mg/mL
of G418. G418-resistant colonies were selected based on cell
growth and morphology. One electroporation session was
performed and a total of 209 clones were isolated and amplified
in 96-well plates. Duplicates of 96-well-plates were made; one
copy was frozen down and the other copy was amplified on
gelatine to be used for genomic DNA preparation. Clones were
screened by PCR for homologous recombination and verified by
Southern blotting. Altogether, PCR, sequencing and Southern
blot screening allowed the characterization of 10 recombined
clones, 7 of which were suitable for blastocyst injection.
Recipient blastocysts were isolated from pregnant C57BL/6J
females (Health status VAF – Virus Antibody Free). Based on
screening results and morphological criteria, ES cell clones were
Figure 1. Generation of recombinant Fgf10iCre locus. (A, B) Cre-ERT2-IRES-eYFP-Neo construct was introduced in frame with ATG of exon 1 by
homologous recombination. Genes coding for Neomycin resistance (Neo) and Diphtheria Toxin A were used for positive and negative selection
respectively. (C) Chimeras carrying the Neo cassette were crossed with C57BL/6J mice ubiquitously expressing Flp recombinase to generate
heterozygous knock-in mice lacking the Neo cassette (D). Primers used for genotyping are shown as black arrows. Note that primers P1 and P2 detect
the wild-type locus (297 bp band) whereas primers P3 and P4 detect the recombined locus (271 bp band). C: control; DTA: Diphtheria Toxin A; pGK:
Phosphoglycerate kinase promoter.
doi:10.1371/journal.pone.0038452.g001
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injected into C57BL/6J blastocysts. Injected blastocysts were
then re-implanted into OF1 pseudo-pregnant females and
allowed to develop to term. Four of the highly chimeric males
generated were selected to breed with C57BL/6J Flp-deleter
mice (health status SOPF – Specific and Opportunist Pathogen
Free) to allow the germline excision of the neomycin selection
cassette.
Genotyping
Two primer pairs were used to genotype Fgf10iCre knock-in
mice. Primers P1 (5’-AGCAGGTCTTACCCTTCCAG-
TATGTTCC-3’) and P2 (5’-CTCCTTGGAGGTGATTG-
TAGCTCCG-3’) were used to detect the wild-type allele
(297 bp band) whereas primers P3 (5’-CAAACCCCAAAAGAA-
CAGCTTTGTGTAC-3’) and P4 (5’-GACATTT-
GAGTTGCTTGCTTGGCACT-3’) were used to detect the
knock-in allele (271 bp band). The PCR program consists of a
denaturation step at 94uC for 2 min, followed by 35 cycles of
denaturation (94uC for 30s), annealing (65uC for 30s) and
extension steps (68uC for 300s). The program ends with a
completion step at 68uC for 480s. Each PCR tube contains 2.6 U
of Expand Long Template Polymerase in 5 mL of Reaction buffer
3 (Roche Applied Science, Mannheim, Germany), 15 pmol of
each primer, 0.5 mM dNTPs and 10 ng of genomic DNA in a
final volume of 50 mL.
Mice and Tamoxifen Administration
Tomatoflox/flox reporter mice (B6;129S6-Gt(ROSA)26Sortm9(CAG-
tdTomato)Hze/J) [13] were purchased from Jackson lab and
Fgf10flox/flox mice [14,15] were a kind gift from Professor Suzanne
L. Mansour (University of Utah, USA). Embryonic day 0.5
(E0.5) was assigned to the day when a vaginal plug was detected.
Mice were housed in an SPF environment. Animal experiments
were approved by the Regierungspraesidium Giessen (Project
ID763, approval number RP GI/20-Nr38/2011, 548_GP) and
by the Animal Research Committee at Children’s Hospital Los
Angeles (Protocol number 31-11) in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institute of Health. The
approval identification for Children’s Hospital Los Angeles is
AAALAC A3276-01.
Tamoxifen stock solution was prepared by dissolving tamoxifen
powder (T5648, Sigma, Schnelldorf, Germany) in corn oil at a
concentration of 20 mg/mL at room temperature. Pregnant
females carrying Fgf10iCre/+; Tomatoflox/+ embryos received a single
intra-peritoneal (IP) injection of 0.075 mg tamoxifen per gram of
body weight. For continuous tamoxifen exposure, pregnant
females were fed tamoxifen-containing food (0.4 g of tamoxifen
per kg of food) (Altromin, Lage, Germany). Dissected embryos
were examined using Leica M205 FA fluorescent stereoscope
(Leica, Wetzlar, Germany) and images were acquired using Leica
DFC360 FX camera. Cecum lengths were measured using Leica’s
LAS AF software and digit peripheries were measured using
Image J software (NIH, USA). Figures were assembled in Adobe
Photoshop CS5.
X-Gal Staining
X-Gal staining was performed as previously described [16].
Briefly, Fgf10LacZ/+ lungs were dissected out in Hank’s solution
(HBSS) from E18.5 embryos, shortly fixed in 4% PFA, washed in
PBS and incubated with LacZ buffer solution for 10 min. Then,
they were incubated with LacZ buffer solution containing 40 mg/
mL X-Gal (Sigma) at 37uC overnight.
Quantitative Real-time PCR and Statistical Analysis
Freshly isolated embryos and lungs were lysed and RNA was
purified using RNeasy kit (Qiagen, Hilden, Germany). E11.5 and
E13.5 embryos were homogenized using QiaShredder columns
(Qiagen) whereas lungs from older tissues were homogenized using
Bullet Blender Blue (Next Advance, NY, USA). 1 mg of RNA was
used for cDNA synthesis using Quantitect Reverse Transcription
kit (Qiagen). Primers and probes for Fgf10, Cre and b-actin were
designed using Universal ProbeLibrary Assay Design center
(Roche Applied Science, available online at https://www.roche-
applied-science.com/sis/rtpcr/upl/index.jsp?id =UP030000).
More details about the used primers and probes can be found in
Table S1. Quantitative real-time PCR (qPCR) was performed
using LightCycler 480 real-time PCR machine (Roche Applied
Science). Samples were run in triplicates using b-actin as a
reference gene and the DDCT method was used for relative
quantification. Data were assembled using GraphPad Prism
software (GraphPad Software, USA) and statistical analyses were
performed using Student’s t-test (for comparing two groups) or
One-way ANOVA (for comparing three or more groups). Data
were considered significant if P,0.05.
Results
Generation of Fgf10iCre (C57BL/6-Fgf10Cre-ERT2-YFP/J)
Driver Line
129Sv ES cells were electroporated with a targeting vector
containing the 59 end of exon 1 of Fgf10 open reading frame
(Fig.1A, B). Immediately downstream of the start codon is the
coding sequence of a tamoxifen-inducible form of Cre recombi-
nase (Cre-ERT2) [17], followed by IRES sequence, enhanced YFP
and Neomycin-resistance gene (Neo) respectively. Resistant ES cell
clones were selected, screened by PCR and then verified by
Southern blotting. Selected ES clones were injected into C57BL/
6J blastocysts to generate chimeric pups (Fig. 1C). Chimeras were
then crossed with C57BL/6J mice ubiquitously expressing Flp
recombinase to generate heterozygous Fgf10iCre knock-in mice
where the Neo cassette was totally excised (Fig. 1D).
Insertion of the Cre-ERT2 Cassette in Exon1 Results in
Fgf10 Loss of Function
To determine whether the insertion of Cre-ERT2 in the
endogenous Fgf10 locus led to loss of function of Fgf10, Fgf10iCre
heterozygous animals were crossed together and embryos were
harvested at E12.5. Fgf10iCre homozygous embryos suffered from
lung and limb agenesis in addition to cecal and colonic atresia,
consistent with complete loss of function of Fgf10 (Fig. 2A–C; n = 4;
penetrance = 100%). Fgf10iCre/+ embryos were used as controls.
qPCR revealed minimal expression levels for Fgf10 in Fgf10iCre/iCre
embryos (Fig. 2D; n = 4) compared to Fgf10iCre/+ (Fig. 2D; n = 5;
P,0.0001) and Fgf10+/+ embryos (Fig. 2D; n = 5; P,0.0001).
Labeling of Fgf10-positive Cells
In order to test the recombinase activity of Cre-ERT2, Fgf10iCre
heterozygous mice were crossed with Tomatoflox/flox reporter mice.
Pregnant females received a single IP injection of tamoxifen or
corn oil at E15.5 and embryos were harvested at E18.5. No
recombination was observed in Fgf10+/+; Tomatoflox/+ embryos
(Fig. 3A–D; n = 4). Recombination was observed in the ears
(Fig. 3A’, A’’), skin (Fig. 3B’, B’’), limbs (Fig. 3C’, C’’), ceca
(Fig. 3D’, D’’) and lungs (Fig. 4A’-C’) of Fgf10iCre/+; Tomatoflox/+
embryos (n= 3; penetrance = 100%). Labeled cells in the skin were
arranged in discrete spots (Fig. 3B’, B’’). In the limbs, labeled cells
Fgf10 Knock in Line and Mesenchymal Progenitors
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were abundant at the tips of the digits as well as more proximal
regions (Fig. 3C’, C’’). In the cecum, however, elongated cells were
labeled (Fig. 3D’, D’’).
When examining the lungs from Fgf10iCre/+; Tomatoflox/+
embryos, Tomato-positive cells were detected throughout the
mesenchyme (Fig. 4A’; n = 3). Interestingly, the signal was intense
in interlobular septae (Fig. 4B’). In the trachea, Tomato-positive
cells were arranged in ring-like structures (Fig. 4C’). X-Gal
staining of Fgf10LacZ/+ lungs at E18.5 revealed similar sites of Fgf10
expression (Fig. 4A’’-C’’; n = 8). The expression of the YFP
reporter from the IRES sequence could not be detected in any
of the embryos. Tomato-positive cells were not detected in
Fgf10iCre/+; Tomatoflox/+ lungs from corn oil-injected females (Data
not shown; n = 6).
Inducible Conditional Gene Inactivation
To test the potential use of this line for gene inactivation studies,
Fgf10iCre/+; Tomatoflox/flox mice were crossed with mice carrying a
‘floxed’ version of Fgf10 (Fgf10flox/flox) [14]. Cre activity was induced
by tamoxifen food from E8.5 to E14.5. By using the Tomatoflox
reporter as readout of Cre activity, recombination was observed in
the limbs, lungs and ceca (Fig. 5C, D, G, H, L; n = 3;
penetrance = 100%). Fgf10iCre/flox; Tomatoflox/+ embryos suffered
from diverse developmental abnormalities (n = 3; pene-
trance = 100%). A formation defect characterized by webbed
digits was observed at the level of the forelimbs as compared to
their Fgf10+/flox; Tomatoflox/+ control littermates. The phenotype
was quantified by measuring the periphery of the digits (Fig. 5H vs.
E, M; n = 3; P,0.0001). Hindlimbs did not show any obvious
abnormalities. The lung showed an abnormal shape and suffered
from branching simplification as illustrated by the reduced
number of terminal buds in the accessory lobe (Fig. 5C vs. B, G
vs. F, J; n = 3; P,0.05). The cecum, on the other hand, was shorter
Figure 2. Fgf10iCre is a null allele for Fgf10. E12.5 Fgf10iCre/iCre embryos show agenesis of the limbs (A, A’) and lung (B, B’) as well as
cecal and colonic atresia (C, C’). Arrowheads indicate sites of limb agenesis and dashed lines mark the epithelium in the cecum. Fgf10iCre/+
embryos were used as controls. (D) Fgf10 relative mRNA levels as quantified by qPCR. Fgf10iCre/iCre embryos (n= 4) express minimal Fgf10 levels
compared to Fgf10iCre/+ (n= 5) and Fgf10+/+ embryos (n= 5). Data are shown as average values 6 SEM. * P,0.05; *** P,0.0001. Ce: cecum; Co: colon.
doi:10.1371/journal.pone.0038452.g002
Figure 3. Tomato expression in E18.5 Fgf10iCre/+; Tomatoflox/+
embryos. Recombination was induced at E15.5 by a single IP injection
of tamoxifen. Note the absence of Tomato expression in Fgf10+/+;
Tomatoflox/+ embryos (A–D). Tomato-positive cells are detected in the
ear, skin, limbs and cecum (A’–D’). (A’’–D’’) Higher magnifications of
dotted boxes in A’, B’, C’, D’. n= 3. Tam: tamoxifen.
doi:10.1371/journal.pone.0038452.g003
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in Fgf10iCre/flox; Tomatoflox/+ embryos as compared to littermate
controls (Fig. 5L vs. I, K; n = 3; P,0.05).
Mismatch between Cre and Fgf10 Expression Levels
In order to investigate the expression levels of Cre from the
Fgf10iCre locus, timed-pregnant females carrying Fgf10iCre/+ em-
bryos were sacrificed at different developmental stages and Fgf10
and Cre expression levels were assessed by qPCR by comparing
mRNA abundance from different stages to E11.5. Fgf10 expression
levels progressively increased in Fgf10iCre/+ embryos from E11.5
(n = 5) to E13.5 (n = 3; P,0.01) and E18.5 (n = 7; P,0.001) and
were maintained postnatally at P2 (n = 2; P,0.05), P12 (n= 4;
P,0.0001) and P161 (n = 3; P,0.001); however, Cre expression
levels, from the same embryos, showed a slower increase from
E11.5 (n= 5) to E13.5 (n = 3; P,0.05) and E18.5 (n = 7; P,0.01)
and then dropped postnatally at P2 (n = 2; P,0.05), P12 (n= 4;
P,0.001) and P161 (n = 3; P,0.001) (Fig. 6A). In spite of low Cre
expression levels postnatally, single IP injections of tamoxifen at P1
or P4 led to significant recombination in Fgf10iCre/+; Tomatoflox/+
lungs at P6 and P60 respectively (Fig. 6D–G; n = 4; pene-
trance = 100%). Induction in P1 Tomatoflox/+ pups (single trans-
genics) did not reveal any recombination at P10 (Fig. 6B, C; n = 2).
Last but not least, serial tamoxifen IP injections (one daily injection
for one week), followed by a 10-day tamoxifen diet and 10-day
normal diet, revealed recombination in the trachea and lung of
Fgf10iCre/+; Tomatoflox/+ adult mice (Fig. 6H, I; n = 3; pene-
trance = 100%).
The 3 kb region downstream of Fgf10 transcriptional start site,
which was deleted upon homologous recombination, was analyzed
for putative regulatory elements by comparing transcription factor
binding sites conserved between mouse and human (using rVista,
http://rvista.dcode.org). The analysis revealed the presence of
several conserved transcription factor binding site-dense regions
(Fig. 7A). Interestingly, the 716 bp stretch at the 39 end of the
deleted region contains putative binding sites for Smad4, Nkx2.5,
Tbx5 and Isl1. Furthermore, the deleted region was analyzed for
lung-related histone modifications using UCSC Genome Browser
(http://genome.ucsc.edu). The analysis revealed the presence of a
dense H3K4me3 (histone H3 trimethylated at Lys4) modification
site overlapping exon 1-intron 1 boundary (Fig. 7B).
Discussion
Fgf10 is a morphogen that is crucial for the embryonic
development of many organs including the lung, duodenum,
cecum, colon, pancreas, limb and mammary placodes. Fgf10
knockout mice suffer from agenesis of the corresponding organs,
thus limiting any real use of these mice in studying the behavior or
lineage commitment of Fgf10-positive cells. On the other hand,
due to the stability of b-Galactosidase, the Fgf10LacZ transgenic line
allows non-inducible transient tracing of Fgf10-positive cells in
many organs. However, the gold standard for an optimal lineage
tracing tool relies on the inducibility of constitutive cell labeling via
the controlled activation of Cre recombinase. Then, short- and
long-term lineage commitment can be investigated. Therefore, the
data obtained with the Fgf10LacZ line should always be validated
using the proper Cre inducible line. Nevertheless, this line has
helped identify the progeny of Fgf10-positive cells in the heart,
lung, gut, mammary glands, brain [4,5,7,8,9,10,11] and limbs
[Hajihosseini and Bellusci, unpublished results]. Thus, the Fgf10iCre
knock-in line characterized in this paper represents a novel tool
that bypasses the pitfalls associated with the Fgf10LacZ transgenic
line. This is because Fgf10-positive cells are exclusively labeled
Figure 4. Tomato expression in E18.5 Fgf10iCre/+; Tomatoflox/+
lungs. Recombination was induced at E15.5 by a single IP injection of
tamoxifen. Note the absence of Tomato expression in Fgf10+/+;
Tomatoflox/+ lungs (A; n= 3). The regions in the dotted boxes are
magnified in (B) and (C). Tomato-positive cells are observed in the lung
mesenchyme and interlobular septae of Fgf10iCre/+; Tomatoflox/+ lungs
(white arrows) (A’, B’; n= 3). Inset in B’ shows high magnification of
interlobular septae. Labeled cells in the trachea arrange in ring-like
structures (black arrows) (C’; n= 3). (A’’-C’’; n= 8) X-Gal staining of
Fgf10LacZ/+ lungs at E18.5. Inset in B’’ shows high magnification of
interlobular septae. Tam: tamoxifen.
doi:10.1371/journal.pone.0038452.g004
Figure 5. Inducible conditional Fgf10 inactivation using
Fgf10iCre driver line. Cre was activated by tamoxifen food from E8.5
to E14.5 in Fgf10iCre/flox; Tomatoflox/+ embryos. Labeled cells are present
in the limbs, lung and cecum (D, G, H, L). Note the webbing of the
digits in the forelimbs (arrows indicate webbing sites and dashed lines
indicate peripheries) (H vs. E, M) and the hypomorph-like phenotype
in the cecum (L vs. I, K). Fgf10iCre/flox; Tomatoflox/+ lungs show a
deformed shape (C vs. B) as well as branching simplification (G vs. F,
J). Dashed lines indicate the epithelium in the lung (F, G) and cecum (I,
L). n= 3. Data are shown as average values 6 SEM. * P,0.05; ****
P,0.0001; Tam: tamoxifen.
doi:10.1371/journal.pone.0038452.g005
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upon tamoxifen injection, after which labeled cells can be traced
and characterized. A previous report has shown that intra-
peritoneally administered tamoxifen reaches effective levels in the
embryonic circulation within 12 hours, after which it is cleared
from the pregnant female within 12 hours [18]. This 24-hour time
frame allows accurate labeling of Fgf10-positive cells.
In this study, we induced recombination in pregnant females
carrying Fgf10iCre/+; Tomatoflox/+ embryos at E15.5. At E18.5,
lineage-labeled cells were found in the ears of the embryos
(Fig. 3A’’) and this observation is consistent with previously
published reports that describe the role of Fgf10 in inner ear
formation [19]. Moreover, labeled cells were observed in the skin
(Fig. 3B’’) where Fgf10 is known to be expressed in the dermal
papillae [20]. In the lung, labeled cells were dispersed throughout
the mesenchyme (Fig. 4A’). However, the signal was more
pronounced in interlobular septae (Fig. 4B’). Further studies need
to be performed in order to explain this observation. As for the
trachea, labeled cells were arranged in discrete ring-like structures
(Fig. 4C’). This pattern is consistent with previously published
reports about the role of Fgf10 in tracheal cartilage ring formation
in mice [21,22]. We also used Fgf10LacZ/+ lungs from the same
stage (E18.5) to validate our data. As expected, X-Gal staining of
Fgf10LacZ/+ lungs revealed similar sites of Fgf10 expression
(Fig. 4A’’-C’’).
For functional inactivation studies, we generated E14.5
Fgf10iCre/flox; Tomatoflox/+ embryos in which Cre had been activated
since E8.5. By virtue of the embedded Tomatoflox reporter, we were
able to locate recombination sites and thus, we restricted our
diagnostic to those specific sites. An abnormal phenotype,
characterized by webbing of the digits, was observed in the
forelimbs (Fig. 5H vs. E, M). This finding agrees with previous
reports about the involvement of Fgf10 misregulation in digit
abnormalities such as syndactyly [23], [Al Alam and Bellusci, in
revision]. Moreover, Fgf10iCre/flox; Tomatoflox/+ lungs showed clear
developmental abnormalities characterized by a deformed shape
as well as branching simplification (Fig. 5C vs. B, G vs. F, J). This
phenotype is similar to that obtained by Abler et al. who used a
general mesenchymal driver line (Dermo1Cre) to perform condi-
tional gene inactivation of Fgf10 [14]. Last but not least, our
research group has previously demonstrated that the gut is a major
site of Fgf10 expression and that hypomorphic Fgf10 embryos
(Fgf10LacZ/2) suffered from cecal atresia [4]. Our data agrees with
this finding as Fgf10iCre/flox; Tomatoflox/+ embryos suffered from a
hypomorph-like phenotype at the level of the cecum upon partial
loss of function of Fgf10 (Fig. 5L vs. I, K).
One drawback of the Fgf10iCre line is the mismatch between Cre
and Fgf10 expression levels as examined at different developmental
stages by qPCR (Fig. 6A). To understand the inefficient expression
of Cre from the Fgf10iCre locus, we performed a bioinformatic
analysis for the 3 kb deleted sequence downstream of ATG codon
of exon 1 of Fgf10 gene using online tools (Fig. 7). The analysis
revealed the presence of H3K4me3 site overlapping exon 1-intron
1 boundary. This histone modification is known to be associated
with the 59 end of actively transcribed genes [24]. On the other
hand, several conserved binding sites for lung-related transcription
factors were detected, including binding sites for Smad4, Nkx2.5,
Tbx5 and Isl1. Tbx5 is thought to directly control Fgf10 expression
in the lung mesenchyme [25]. Moreover, a recent report has
shown that ISL1 regulates FGF10 transcription within the second
heart field by binding to an enhancer element in intron 1 of FGF10
Figure 6. Mismatch between Cre and Fgf10 expression levels in Fgf10iCre/+ embryos. (A) Fgf10 and Cre relative mRNA levels as determined
by qPCR. For RNA preparation, whole embryos were used at E11.5 (n= 5) and E13.5 (n= 3) whereas lungs were used at E18.5 (n= 7), P2 (n= 2), P12
(n= 4) and P161 (n= 3). Fgf10 expression levels increase throughout development and are maintained postnatally while Cre levels slowly increase
throughout development and are minimal postnatally. (B) Induction in P1 Tomatoflox/+ pups reveals no recombination at P10 in the lung (n= 2). The
area in the dotted box is magnified in (C). Inset in C shows high magnification with unlabeled cells. (D-G; n= 4) Induction in P1 and P4 Fgf10iCre/+;
Tomatoflox/+ pups reveals recombination at P6 and P60 in the lung respectively. Insets in E and G show high magnification with labeled cells. (H, I;
n= 3) Tamoxifen-induced recombination in lungs from Fgf10iCre/+; Tomatoflox/+ adult mice. Labeled cells are detected in the trachea and lung lobes.
Inset in I shows high magnification with labeled cells. Data are shown as average values 6 SEM. * P,0.05; ** P,0.01; *** P,0.001; **** P,0.0001.
doi:10.1371/journal.pone.0038452.g006
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gene [26]. Altogether, these data suggest the presence of key
regulatory elements in intron 1 critical for the maintenance of
Fgf10 expression over time. Nonetheless, this line allows to target a
subset of Fgf10-positive cells after birth allowing to study the
lineage commitment of these cells during homeostasis and during
the repair process after injury.
Alternative strategies that would bypass potential consequences
on Cre expression levels include fusion of Cre-ERT2 in frame with
the ATG codon of Fgf10 without deleting intronic sequences, thus
preserving putative regulatory elements and matching Cre expres-
sion levels to endogenous Fgf10. Another approach would be the
insertion of IRES-Cre-ERT2 in the 3’ UTR downstream of Fgf10
stop codon. In this case, Fgf10 would still be expressed at
physiological levels but Cre expression levels would depend greatly
on the activity of the IRES element.
In conclusion, the Fgf10iCre knock-in line described in this paper
is a novel tool that allows labeling and tracking of Fgf10-positive
cells. The mosaic recombination pattern, as illustrated by the
Tomatoflox reporter, makes this line convenient for clonal analysis,
especially when a partial loss of function approach is desired. This
tool can potentially bring insight on the role of Fgf10-positive
progenitor cells in development and repair after injury.
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